The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The Penumbra System: A Mechanical Device for the Treatment of Acute Stroke due to Thromboembolism
Open accessAbstract
BACKGROUND AND PURPOSE: Data from recent reports have indicated that mechanical thrombectomy may have potential as a treatment for acute ischemic stroke. The purpose of this study was to assess the safety and performance of the Penumbra System (PS): a novel mechanical device designed to reduce clot burden in acute stroke due to large-vessel occlusive disease. MATERIALS AND METHODS: A prospective, single arm, independently monitored and core laboratory adjudicated trial enrolled subjects with an acute neurologic deficit consistent with acute stroke, presenting within 8 hours of symptom onset and an angiographically verified occlusion (Thrombolysis in Myocardial Infarction [TIMI] grade 0 or 1) of a treatable intracranial vessel. The primary end point was revascularization of the target vessel to TIMI grade 2 or 3. Secondary end points were the proportion of subjects who achieved a modified Rankin Scale (mRS) score of 2 or less or a 4-point improvement on the National Institutes of Health Stroke Scale (NIHSS) score at 30-day follow-up, as well as all-cause mortality. RESULTS: Twenty-three subjects were enrolled, and 21 target vessels were treated in 20 subjects by the PS. At baseline, mean age was 60 years, mean mRS score was 4.6, and mean NIHSS score was 21. Postprocedure, all 21 of the treated vessels (100%) were successfully revascularized by the PS to TIMI 2 or 3. At 30-day follow-up, 9 subjects (45%) had a 4-point or more NIHSS improvement or an mRS of 2 or less. The all-cause mortality rate was 45% (9 of 20), which is lower than expected in this severe stroke cohort, where 70% of the subjects at baseline had either an NIHSS score of more than 20 or a basilar occlusion. CONCLUSION: Thus, early clinical experience suggests that the PS allows revascularization in certain subjects experiencing acute ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial
Smith, W. S., Sung, G., Starkman, S., Saver, J. L., Kidwell, C. S., Gobin, Y. P., Lutsep, H. L., Nesbit, G. M., Grobelny, T., Rymer, M. M., et al. (2005) · Stroke · doi:10.1161/01.str.0000171066.25248.1d · Cited by 1,312
Brandt, T., von Kummer, R., Müller-Küppers, M., & Hacke, W. (1996) · Stroke · doi:10.1161/01.str.27.5.875 · Cited by 484
Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T. (2007) · Stroke · doi:10.1161/strokeaha.107.488551 · Cited by 481
MERCI 1: A Phase 1 Study of Mechanical Embolus Removal in Cerebral Ischemia
Pierre Gobin, Y., Starkman, S., Duckwiler, G. R., Grobelny, T., Kidwell, C. S., Jahan, R., Pile-Spellman, J., Segal, A., Vinuela, F., & Saver, J. L. (2004) · Stroke · doi:10.1161/01.str.0000147718.12954.60 · Cited by 443
Smith, W. S. (2006) · PubMed Central · Cited by 329
Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
Jansen, O., Schellinger, P., Fiebach, J., Hacke, W., & Sartor, K. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01146-0 · Cited by 258
Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation.
Jansen, O., von Kummer, R., Forsting, M., Hacke, W., & Sartor, K. J. (1995) · PubMed Central · Cited by 247
Intracranial Hemorrhage Associated With Revascularization Therapies
Khatri, P., Wechsler, L. R., & Broderick, J. P. (2007) · Stroke · doi:10.1161/01.str.0000254524.23708.c9 · Cited by 227
Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: The Message of Melt
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.490417 · Cited by 67
Beyond tissue plasminogen activator: Mechanical intervention in acute stroke
Leary, M. C., Saver, J. L., Gobin, Y. P., Jahan, R., Duckwiler, G., Viñuela, F., Kidwell, C. S., Frazee, J. G., & Starkman, S. (2003) · Annals of Emergency Medicine · doi:10.1067/mem.2003.194 · Cited by 61
Neuroendovascular rescue: Interventional treatment of acute ischemic stroke
Gomez, C. R., Orr, S. C., & Soto, R. D. (2002) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-002-0020-6 · Cited by 6
Cited by
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,657
The Penumbra Pivotal Stroke Trial Investigators (2009) · Stroke · doi:10.1161/strokeaha.108.544957 · Cited by 959
Khatri, P., Yeatts, S. D., Mazighi, M., Broderick, J. P., Liebeskind, D. S., Demchuk, A. M., Amarenco, P., Carrozzella, J., Spilker, J., Foster, L. D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70066-3 · Cited by 416
Ischemic stroke in the elderly: an overview of evidence
Chen, R.-L., Balami, J. S., Esiri, M. M., Chen, L.-K., & Buchan, A. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.36 · Cited by 291
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic
Yepes, M., Roussel, B. D., Ali, C., & Vivien, D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.006 · Cited by 286
Metadata
- Authors
- Bose, A., Henkes, H., Alfke, K., Reith, W., Mayer, T. E., Berlis, A., Branca, V., & Sit, S. P.
- Venue
- American Journal of Neuroradiology
- Published
- 2008-05-22
- Volume
- 29
- Issue
- 7
- Pages
- 1409-1413
- ISSN
- 0195-6108 (ISSN-L)
- 1936-959X
- OpenAlex
- W2115268351
- Cited by
- 341
- References
- 14
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.